搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
13 小时
on MSN
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
7 天
He's a doctor studying why lung cancer rates are rising in Asian Americans with no smoking ...
Stanford University medical professor Dr. Bryant Lin was diagnosed with stage IV lung cancer despite never smoking. Now, he's ...
mskcc.org
10 天
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
19 小时
on MSN
Computational model for drug resistance assessment can improve treatment for leukemia and ...
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
12 小时
on MSN
Report: RI ranks high for lung cancer screening, treatment
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
4 天
on MSN
Lung cancer treatment access: the hidden challenges patients face
By: Nicola MawsonAnyone who has seen a loved one battle lung cancer will tell you just how debilitating it is, watching them ...
10 天
Lung cancer is the leading cause of cancer deaths here in Florida. Here’s why
Floridians are at high risk for lung cancer, and many are waiting too long to get screened, which affects their survival rate ...
16 小时
SF doctor starting initiative aimed at early detection of lung cancer in women
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
30 分钟
AstraZeneca: IMFINZI (durvalumab) approved in the US as first and only immunotherapy ...
Based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo AstraZeneca's IMFINZI (durvalumab) has been approved in the US for the treatment of adult ...
emjreviews.com
5 小时
Thrombosis Risks Rise in ICI-Treated Lung Cancer
Discover the heightened thromboembolic risk for metastatic lung cancer patients on immune checkpoint inhibitors. Learn about ...
oncnursingnews
2 天
Lung Cancer Survival Improves, But Gaps in Biomarker Testing Remain
According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈